Skip to main content
. 2022 Aug 15;14(8):1528–1539. doi: 10.4251/wjgo.v14.i8.1528

Figure 2.

Figure 2

Profile of targetable gene fusions in gastric cancer. A: The types and proportion of 24 gene fusions. Others included targetable ALK, RET, NTRK2, NRG1, and EGFR fusions. Four fusions without targetable genes were excluded from the analysis; B: Comparison of gene fusion frequencies in our cohort and the OrigiMed2020 and The Cancer Genome Atlas (TCGA) cohorts. No statistical differences were found among the cohorts.